The results showed that the levels of ABCB1, ALOX5, NF-κB, and Caspase9 (Figure 5a–d) were significantly increased in the mice with gastric ulcers in the model group, but pretreatment with the CHRs reduced these expressions in a dose-dependent manner. The gene discussed is ALOX5; the disease is gastric ulcer.